Shutong Shen

1.0k total citations
32 papers, 834 citations indexed

About

Shutong Shen is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Shutong Shen has authored 32 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Cardiology and Cardiovascular Medicine and 11 papers in Cancer Research. Recurrent topics in Shutong Shen's work include MicroRNA in disease regulation (6 papers), Cardiac Fibrosis and Remodeling (6 papers) and Cardiovascular Function and Risk Factors (5 papers). Shutong Shen is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cardiac Fibrosis and Remodeling (6 papers) and Cardiovascular Function and Risk Factors (5 papers). Shutong Shen collaborates with scholars based in China, Netherlands and Romania. Shutong Shen's co-authors include Yihua Bei, Junjie Xiao, Lichan Tao, Xiaohui Cao, Lizhou Sun, Yuhong Xu, Jin Bai, Haiwei Yang, Xinli Li and Xinli Li and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Circulation Research.

In The Last Decade

Shutong Shen

32 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shutong Shen China 15 383 212 212 126 125 32 834
Fernándo López-Barrera Mexico 12 204 0.5× 56 0.3× 110 0.5× 72 0.6× 55 0.4× 16 677
Delyth Graham United Kingdom 18 232 0.6× 58 0.3× 293 1.4× 75 0.6× 73 0.6× 32 839
Fang Guo China 19 197 0.5× 90 0.4× 162 0.8× 60 0.5× 324 2.6× 42 816
Constantijn Franssen Belgium 13 217 0.6× 36 0.2× 874 4.1× 108 0.9× 142 1.1× 30 1.2k
Kaimin Guo China 12 259 0.7× 124 0.6× 54 0.3× 85 0.7× 49 0.4× 64 629
Greta L. Hoetzer United States 15 210 0.5× 67 0.3× 341 1.6× 81 0.6× 18 0.1× 23 856
Zhifu Guo China 16 399 1.0× 319 1.5× 110 0.5× 103 0.8× 24 0.2× 38 906
Imtiaz A. Samjoo United States 15 211 0.6× 56 0.3× 43 0.2× 43 0.3× 70 0.6× 42 955
Amanda J. Edgley Australia 18 217 0.6× 39 0.2× 373 1.8× 108 0.9× 19 0.2× 38 770

Countries citing papers authored by Shutong Shen

Since Specialization
Citations

This map shows the geographic impact of Shutong Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shutong Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shutong Shen more than expected).

Fields of papers citing papers by Shutong Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shutong Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shutong Shen. The network helps show where Shutong Shen may publish in the future.

Co-authorship network of co-authors of Shutong Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Shutong Shen. A scholar is included among the top collaborators of Shutong Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shutong Shen. Shutong Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Shutong, Fei Xu, Xiehui Chen, et al.. (2022). Highly Purified Eicosapentaenoic Acid Alleviates the Inflammatory Response and Oxidative Stress in Macrophages during Atherosclerosis via the miR‐1a‐3p/sFRP1/Wnt/PCP‐JNK Pathway. Oxidative Medicine and Cellular Longevity. 2022(1). 9451058–9451058. 7 indexed citations
2.
Shen, Shutong, Rongrong Gao, Yihua Bei, et al.. (2017). Serum Irisin Predicts Mortality Risk in Acute Heart Failure Patients. Cellular Physiology and Biochemistry. 42(2). 615–622. 44 indexed citations
3.
Xiao, Junjie, Hui Liu, Dragoş Crețoiu, et al.. (2017). miR-31a-5p promotes postnatal cardiomyocyte proliferation by targeting RhoBTB1. Experimental & Molecular Medicine. 49(10). e386–e386. 34 indexed citations
4.
Cao, Yunshan, Shutong Shen, Heling Fu, et al.. (2017). Trimedazidine alleviates pulmonary artery banding-induced acute right heart dysfunction and activates PRAS40 in rats. Oncotarget. 8(54). 92064–92078. 4 indexed citations
5.
Shen, Shutong, Huimin Jiang, Yihua Bei, et al.. (2017). Qiliqiangxin Attenuates Adverse Cardiac Remodeling after Myocardial Infarction in Ovariectomized Mice via Activation of PPARγ. Cellular Physiology and Biochemistry. 42(3). 876–888. 27 indexed citations
6.
Shen, Shutong, Huimin Jiang, Yihua Bei, Junjie Xiao, & Xinli Li. (2017). Long Non-Coding RNAs in Cardiac Remodeling. Cellular Physiology and Biochemistry. 41(5). 1830–1837. 74 indexed citations
7.
Xu, Ying, Yihua Bei, Shutong Shen, et al.. (2017). MicroRNA-222 Promotes the Proliferation of Pulmonary Arterial Smooth Muscle Cells by Targeting P27 and TIMP3. Cellular Physiology and Biochemistry. 43(1). 282–292. 40 indexed citations
8.
Zhang, Haifeng, Shanshan Li, Qiulian Zhou, et al.. (2016). Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p. Cellular Physiology and Biochemistry. 38(5). 1743–1751. 30 indexed citations
9.
Wang, Hui, Yihua Bei, Shutong Shen, et al.. (2016). miR-21-3p controls sepsis-associated cardiac dysfunction via regulating SORBS2. Journal of Molecular and Cellular Cardiology. 94. 43–53. 114 indexed citations
10.
Wang, Hui, et al.. (2015). Use of microRNAs as Anti-Atherosclerosis. Mini-Reviews in Medicinal Chemistry. 15(6). 452–458. 2 indexed citations
11.
Tao, Lichan, Yihua Bei, Haifeng Zhang, et al.. (2015). Exercise Training Protects Against Acute Myocardial Infarction via Improving Myocardial Energy Metabolism and Mitochondrial Biogenesis. Cellular Physiology and Biochemistry. 37(1). 162–175. 105 indexed citations
12.
Tao, Lichan, et al.. (2015). Tendency for age-specific mortality with hypertension in the European Union from 1980 to 2011.. PubMed. 8(2). 1611–23. 5 indexed citations
13.
Shen, Shutong & Xinli Li. (2015). GW26-e4401 MiR-195-3p/-5p decrease cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts. Journal of the American College of Cardiology. 66(16). C57–C57. 1 indexed citations
14.
Xu, Yuhong, Shutong Shen, Lizhou Sun, et al.. (2014). Metabolic Syndrome Risk after Gestational Diabetes: A Systematic Review and Meta-Analysis. PLoS ONE. 9(1). e87863–e87863. 127 indexed citations
16.
Yu, Di, Tao Chen, Jin Liu, et al.. (2014). Maternal Parity and the Risk of Congenital Heart Defects in Offspring: A Dose-Response Meta-Analysis of Epidemiological Observational Studies. PLoS ONE. 9(10). e108944–e108944. 19 indexed citations
17.
Guo, Qing, Shengbin Dai, Feng Shen, et al.. (2014). VEGF +405G/C (rs2010963) polymorphisms and digestive system cancer risk: a meta-analysis. Tumor Biology. 35(5). 4977–4982. 7 indexed citations
18.
Tao, Lichan, Shutong Shen, & Xinli Li. (2013). Future prospects of Qiliqiangxin on heart failure: epigenetic regulation of regeneration. Frontiers in Genetics. 4. 221–221. 12 indexed citations
19.
Zhu, Jianxi, Wei Shen, Gao Li, et al.. (2013). PI3K/Akt-independent negative regulation of JNK signaling by MKP-7 after cerebral ischemia in rat hippocampus. BMC Neuroscience. 14(1). 1–1. 44 indexed citations
20.
Xu, Pei, Shutong Shen, X. X. Zhang, et al.. (2013). The (TTTA) n polymorphism in intron 4 of CYP19 and the polycystic ovary syndrome risk in a Chinese population. Molecular Biology Reports. 40(8). 5041–5047. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026